REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 96 filers reported holding REGULUS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $23,000 | -78.1% | 23,001 | -63.8% | 0.00% | – |
| Q1 2017 | $105,000 | +337.5% | 63,458 | +493.1% | 0.00% | – |
| Q4 2016 | $24,000 | -68.4% | 10,700 | -53.4% | 0.00% | – |
| Q3 2016 | $76,000 | +55.1% | 22,942 | +35.8% | 0.00% | – |
| Q2 2016 | $49,000 | -54.2% | 16,897 | +9.4% | 0.00% | – |
| Q1 2016 | $107,000 | -51.1% | 15,441 | -38.4% | 0.00% | – |
| Q4 2015 | $219,000 | -53.5% | 25,079 | -65.2% | 0.00% | – |
| Q3 2015 | $471,000 | +106.6% | 72,093 | +246.0% | 0.00% | – |
| Q2 2015 | $228,000 | -70.6% | 20,834 | -54.5% | 0.00% | -100.0% |
| Q1 2015 | $776,000 | +1261.4% | 45,812 | +1184.3% | 0.00% | – |
| Q4 2014 | $57,000 | – | 3,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |